RxDoctor Payments Data

Laura Feder, DO

Family Medicine · Louisville, KYNPI 1043709363

Payments from drug & device makers

$1,515in general payments, 2019–2025

Across 67 payments — averaging $22.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$458
  • AstraZeneca$206
  • Biohaven Pharmaceutical Holding Company Ltd.$173
  • Amgen$129
  • GSK$67
  • Bayer$52
  • plus $429 from 15 others

What the payments were for

  • Food & beverage$1,515100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,515 in reported general payments places this provider in the 60th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$24,281
Medicare patients
157
Services billed
635

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium26$499
Fluticasone Propionate53$430
Famotidine29$421
Albuterol Sulfate HfaAlbuterol Sulfate16$390
Losartan Potassium28$289
Levothyroxine Sodium21$231
Trazodone Hcl13$228
Amlodipine Besylate15$197
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav29$145
Cephalexin37$135
Doxycycline Hyclate21$107
Fluconazole20$81
Mupirocin13$67
Azithromycin17$54
Prednisone18$34

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Amneal Pharmaceuticals LLCLevothyroxine Sodium$20$23121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →